News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Syneron Medical Cuts IPO Price Range To $12-$13 A Share From $14-$16
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Underwriters for Syneron Medical Ltd., a provider of tools for use in non-invasive aesthetic medical procedures, have cut the estimated price range for the company's pending initial public offering to $12 to $13 a share from $14 to $16 a share.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Manufacturing
Repligen strikes $1.5B BioLife buyout to bag cell therapy product pharmas rely on
July 22, 2026
·
2 min read
·
Nick Paul Taylor
IPO
2026 IPO stock tracker: How newly public biotechs are performing
July 22, 2026
·
1 min read
·
Gabrielle Masson
Podcast
Q2 earnings underway, FDA’s CRL kerfuffle, IPOs full speed ahead in H2
July 22, 2026
·
1 min read
·
Jef Akst
Manufacturing
Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesity
July 21, 2026
·
2 min read
·
Nick Paul Taylor